The Food and Drug Administration’s Center for Tobacco Products is offering a grant to support exploratory research utilizing publicly available biospecimens in repositories across the United States. Projects should aim to maximize the scientific value of collections like those from the PATH Study and NHANES, providing researchers with preliminary data for future proposals. Priority will be given to analyses of nationally representative data sets. Applicants must justify the uniqueness of their data set and research questions. Applications are accepted until March 8, 2023.
Opportunity ID: 332007
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-OD-21-004 |
| Funding Opportunity Title: | Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.077 — Family Smoking Prevention and Tobacco Control Act Regulatory Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 10, 2021 |
| Last Updated Date: | Mar 10, 2021 |
| Original Closing Date for Applications: | Mar 08, 2023 |
| Current Closing Date for Applications: | Mar 08, 2023 |
| Archive Date: | Apr 13, 2023 |
| Estimated Total Program Funding: | $1,000,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Independent school districts Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Special district governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications to stimulate exploratory research relevant to the mission of the Food and Drug Administration (FDA) – Center for Tobacco Products (CTP) using existing (publicly available) biospecimens currently stored in repositories in the United States. This will include, but not be limited to, collections associated with the Population Assessment of Tobacco and Health (PATH) Study, the National Health and Nutrition Examination Survey (NHANES), the National Heart, Lung and Blood Institutes (NHLBI) Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC), and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Proposed research should seek to maximize the scientific value of these stored collections and to provide researchers with an opportunity to generate preliminary data for subsequent research proposals. While other publicly available repositories would be considered, depending on analyses to be conducted, nationally representative analyses will receive priority. These applications need to provide justification why the data set is unique, and the research questions cannot be answered from a publicly available, nationally representative, data set. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 332007 Full Announcement-RFA-OD-21-004 -> RFA-OD-21-004-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00265870 | Sep 08, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270342 | Nov 16, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278184 | Nov 08, 2022 | Mar 08, 2023 | View |
Package 1
Mandatory forms
332007 RR_SF424_2_0-2.0.pdf
332007 PHS398_CoverPageSupplement_5_0-5.0.pdf
332007 RR_OtherProjectInfo_1_4-1.4.pdf
332007 PerformanceSite_2_0-2.0.pdf
332007 RR_KeyPersonExpanded_2_0-2.0.pdf
332007 PHS398_ResearchPlan_4_0-4.0.pdf
332007 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332007 RR_Budget_1_4-1.4.pdf
332007 RR_SubawardBudget30_1_4-1.4.pdf
332007 PHS398_ModularBudget_1_2-1.2.pdf
332007 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
332007 RR_SF424_5_0-5.0.pdf
332007 PHS398_CoverPageSupplement_5_0-5.0.pdf
332007 RR_OtherProjectInfo_1_4-1.4.pdf
332007 PerformanceSite_4_0-4.0.pdf
332007 RR_KeyPersonExpanded_4_0-4.0.pdf
332007 PHS398_ResearchPlan_4_0-4.0.pdf
332007 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
332007 RR_Budget_3_0-3.0.pdf
332007 RR_SubawardBudget30_3_0-3.0.pdf
332007 PHS398_ModularBudget_1_2-1.2.pdf
332007 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
332007 RR_SF424_5_0-5.0.pdf
332007 PHS398_CoverPageSupplement_5_0-5.0.pdf
332007 RR_OtherProjectInfo_1_4-1.4.pdf
332007 PerformanceSite_4_0-4.0.pdf
332007 RR_KeyPersonExpanded_4_0-4.0.pdf
332007 PHS398_ResearchPlan_5_0-5.0.pdf
332007 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
332007 RR_Budget_3_0-3.0.pdf
332007 RR_SubawardBudget30_3_0-3.0.pdf
332007 PHS398_ModularBudget_1_2-1.2.pdf
332007 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
